🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this research study is to see how useful it is to look at bi...
Status
Unknown
Location
Princess Margaret Cancer Centre
Start Date
2023-02-23
Trial ID
NCT05065021
Treatments Being Tested
The human epidermal growth factor receptor 2 (HER2) regulates cell growth a...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham
Start Date
2019-09-06
Trial ID
NCT03368729
Treatments Being Tested
The purpose of this study is to evaluate the safety and efficacy of nirapar...
Status
Completed
Location
Aichi Cancer Center Hospital
Start Date
2018-12-26
Trial ID
NCT03759600
Treatments Being Tested
Multicentre, 2 arm, open-label UK randomised phase II trial to determine th...
Status
Completed
Location
University Hospital Southampton, Southampton General Hospital
Start Date
2022-07-11
Trial ID
NCT05455424
Treatments Being Tested
Cabozantinib is an oral, small-molecule tyrosine kinase inhibitor. Its prim...
Status
Completed
Location
Xarxa Assistencial Universitària de Manresa
Start Date
2019-10-14
Trial ID
NCT03425201
Treatments Being Tested
SMMART-ACT is a feasibility pilot study to determine if testing samples fro...
Status
Withdrawn
Location
Multiple Locations
Start Date
2023-01-30
Trial ID
NCT05238831
Treatments Being Tested
The main aim of this study is to check for side effects from treatment with...
Status
Completed
Location
Takeda Selected Site
Start Date
2021-09-13
Trial ID
NCT05021562
Treatments Being Tested
This study will be to combine oral capecitabine and oral niraparib such thz...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2023-03
Trial ID
NCT05519670
Treatments Being Tested
This is a multicenter, open-label, phase 2 study to evaluate the efficacy a...
Status
Completed
Location
GSK Investigational Site
Start Date
2017-09-29
Trial ID
NCT03308942
Treatments Being Tested
This research study is studying a combination of drugs as a possible treatm...
Status
Unknown
Location
Dana Farber Cancer Institute
Start Date
2019-06-06
Trial ID
NCT03891615
Treatments Being Tested